Home Patent Forecast® Sectors Log In   Sign Up   Free Trial   Support   Contact   Pricing  
How it works Patent Forecast® Sectors Pricing Insights
Menu
Enjoy your FREE PREVIEW which shows only 2020 data and 25 documents. For full access, try it free at any time.        

Cannabis: Compositions

Search All Applications in Cannabis: Compositions


Application US20200330425


Published 2020-10-22

Lozenge For Improved Delivery Of Cannabinoids

The present invention relates to a lozenge composition for improved delivery of cannabinoids to mucosal surfaces comprising; i) a mucosal delivery enhancing component comprising one or more cannabinoids, an agent with hydrophobic interacting properties and one or more solid particles, the agent with hydrophobic interacting properties forming an encapsulation of the one or more cannabinoids and the encapsulation being reversibly associated with the one or more solid particles; and ii) an extragranular component blended with the mucosal delivery enhancing component comprising one or more extragranular sugar alcohols


Classification


Much More than Average Length Specification


View the Patent Matrix® Diagram to Explore the Claim Relationships

USPTO Full Text Publication >

4 Independent Claims

  • Independent Claim 1-137. (canceled)

  • Independent Claim 138. A lozenge composition for improved delivery of cannabinoids to mucosal surfaces comprising: i) a mucosal delivery enhancing component comprising one or more cannabinoids, an agent with hydrophobic interacting properties and one or more solid particles, the agent with hydrophobic interacting properties forming an encapsulation of the one or more cannabinoids, the encapsulation being reversibly associated with the one or more solid particlesand ii) an extragranular component blended with the mucosal delivery enhancing component comprising one or more extragranular sugar alcohols.

  • Independent Claim 159. A lozenge composition for improved delivery of cannabinoids to mucosal surfaces comprising: i) a mucosal delivery enhancing component comprising one or more cannabinoids, an agent with hydrophobic interacting properties and one or more solid particles of microcrystalline cellulose, the agent with hydrophobic interacting properties forming an encapsulation of the one or more cannabinoids, the encapsulation being reversibly associated with the one or more solid particles of microcrystalline celluloseand ii) an extragranular component blended with the mucosal delivery enhancing component comprising one or more extragranular sugar alcohols.

  • Independent Claim 160. A lozenge composition for improved delivery of cannabinoids to mucosal surfaces comprising: i) a mucosal delivery enhancing component comprising one or more cannabinoids, an agent with hydrophobic interacting properties and one or more solid particles of sugar alcohol, the agent with hydrophobic interacting properties forming an encapsulation of the one or more cannabinoids, the encapsulation being reversibly associated with the one or more solid particles of sugar alcoholand ii) an extragranular component blended with the mucosal delivery enhancing component comprising one or more extragranular sugar alcohols.